Kannaway Partners with Endocanna Overall health for Sale of Endocannabinoid DNA Test Items

[ad_1]

In an August 1, 2019 Press Release, Health-related Marijuana Inc., a U.S.-primarily based and publicly traded cannabis firm announced that its subsidiary Kannaway, partnered with Endocanna Overall health, Inc., a investigation and improvement biotech firm that specializes in endocannabinoid DNA testing and personalization. Endocanna, which is primarily based in California, specializes in genetic testing with DNA so that CBD customers may possibly have a a lot more customized knowledge.

According to the press release, the two providers will operate with each other to create and distribute endocannabinoid DNA test goods. The agreement gives that Endocanna will deal with the manufacture of the patent-pending Endocannabinoid DNA Test Kits and license the technologies to Kannaway. Customers will be capable to use the kits to decide customized information and other cannabinoids may possibly interact with their body’s regulatory technique. The agreement also offers Kannaway the chance to genetically aligned formulations by Endocanna into Kannaway goods.

Stuart Titus, Health-related Marijuana Inc. CEO, shared in the press release,

“Our target, in addition to providing higher-top quality hemp-derived CBD goods, is to deliver our buyers with education on which CBD goods may possibly operate greatest for them. This partnership creates an chance for us to do this in an initial hyper-customized way and assistance shoppers find out how to incorporate CBD into their daily lives. We are pretty excited about our initial actions in this endeavor with Endocanna, but we also appreciate the development possible of this partnership with the eventual target of producing customized dietary supplement goods to match one’s genetic typing and internal physique chemistry. We appear forward to producing a lengthy-lasting partnership with Endocanna and enhancing final results for a diverse population, such as we have right here in the United States.”

Likewise, Len Could, the CEO and Co-Founder of Endocanna shared in the press release,

“Our partnership with Kannaway gives an chance for us to operate with an business leader in creating the most optimal goods even though advancing the science about CBD. Employing Endocanna Health’s proprietary DNA report, we can personalize and deliver a cannabinoid wellness protocol tailored to an individual’s demands.”

[ad_2]

Latest posts